Cardival Medical, Inc. products

Studies Have Demonstrated a Reduction in Time to Hemostasis and Ambulation When Compared to Manual Compression. CATALYST is designed to provide temporary hemostasis and enhance coagulation for patients requiring manual compression – helping to reduce mean hold time by over 50% and reduce time to ambulation by more than 20% as compared to manual compression.

VASCADE VCS is a fully integrated, extravascular, bioabsorbable femoral access closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in a wide range of patients. The system combines Cardiva’s proven proprietary collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design. For patients and healthcare providers, VASCADE enables rapid hemostasis while minimizing complications.

VASCADE MVP eliminates the need for manual compression and reduces time to ambulation by 64%. Get patients up and moving hours earlier, with significantly less discomfort. The only FDA-approved closure device for use following cardiac ablations.